Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers
Journal of Nutritional Science and Vitaminology · 30.06.2024 · 70 (3) · 203-209
DOI: 10.3177/jnsv.70.203 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Nutritional Science and Vitaminology, erschienen am 30.06.2024. Verfasst von Supawan Buranapin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University. Hauptthemen laut MEDLINE: Cross-Over Studies, Insulin, Blood Glucose, Postprandial Period. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University.
- Faculty of Medicine, Kagawa University.
Zitieren
APA
Buranapin, S., Kosachunhanan, N., Waisayanand, N., Yokoi, H., & Tokuda, M. (2024). Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers. Journal of Nutritional Science and Vitaminology, 70(3), 203-209. https://doi.org/10.3177/jnsv.70.203
Vancouver
Buranapin S, Kosachunhanan N, Waisayanand N, Yokoi H, Tokuda M. Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers. Journal of Nutritional Science and Vitaminology. 2024;70(3):203-209. doi:10.3177/jnsv.70.203
BibTeX
@article{Buranapin2024,
author = {Buranapin, Supawan and Kosachunhanan, Natapong and Waisayanand, Nipawan and Yokoi, Hideto and Tokuda, Masaaki},
title = {Effects of D-Allulose with Sucrose Beverage on Glucose Tolerance and Insulin Levels among Thai Healthy Volunteers},
journal = {Journal of Nutritional Science and Vitaminology},
year = {2024},
volume = {70},
number = {3},
pages = {203--209},
doi = {10.3177/jnsv.70.203}
}
EUVIMED